Raphael Pharmaceutical RAPH
OTC RAPH
$1.51 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Receivables - Net (2024 - 2025)

Updated

Raphael Pharmaceutical (RAPH) recorded Receivables - Net of $2,000 in Q4 2025, unchanged from $2,000 a year earlier.

Analysis

Raphael Pharmaceutical (RAPH) Receivables - Net (2024 - 2025) Analysis & Trends

  • Across earlier years, Receivables - Net came in at $2,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.50 Bn 1,103.09 Bn 19.71 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn
3 AbbVie 500.82 Bn 473.93 Bn 12.70 Bn
4 Merck 367.31 Bn 321.69 Bn 12.21 Bn
5 Novartis Ag 297.77 Bn 261.76 Bn 11.24 Bn
6 Astrazeneca 261.35 Bn 235.04 Bn 12.86 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn
8 Gilead Sciences 190.59 Bn 164.79 Bn 6.22 Bn
9 Pfizer 169.39 Bn 116.04 Bn 10.94 Bn
10 Raphael Pharmaceutical 30.47 Mn 30.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2,000.00
Dec 31, 2024 2,000.00
API Access

Raphael Pharmaceutical Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=RAPH&period=max&api_key=YOUR_API_KEY